Clinical Trial Update: Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection

View source ↗

Summary

This clinical trial studied nevirapine dosing in neonates to prevent mother-to-child transmission of HIV and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• NEVIRAPINE (nevirapine)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Human Immunodeficiency Virus, HIV | Status: COMPLETED